• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

群体免疫:了解 COVID-19。

Herd Immunity: Understanding COVID-19.

机构信息

Genetics, Genomics, and Systems Biology, University of Chicago, Chicago, IL, USA.

Genetics, Genomics, and Systems Biology, University of Chicago, Chicago, IL, USA; Department of Medicine, Section of Genetic Medicine, University of Chicago, Chicago, IL 60637, USA; Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.

出版信息

Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012.

DOI:10.1016/j.immuni.2020.04.012
PMID:32433946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7236739/
Abstract

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has demonstrated the devastating impact of a novel, infectious pathogen on a susceptible population. Here, we explain the basic concepts of herd immunity and discuss its implications in the context of COVID-19.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的出现及其相关疾病 COVID-19,表明了一种新型传染性病原体对易感人群的破坏性影响。在这里,我们解释群体免疫的基本概念,并讨论其在 COVID-19 背景下的意义。

相似文献

1
Herd Immunity: Understanding COVID-19.群体免疫:了解 COVID-19。
Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012.
2
The false promise of herd immunity for COVID-19.新冠病毒群体免疫的虚假承诺。
Nature. 2020 Nov;587(7832):26-28. doi: 10.1038/d41586-020-02948-4.
3
Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.微生物组的影响:针对病毒病不断发展群体免疫的范例。
Viruses. 2020 Oct 10;12(10):1150. doi: 10.3390/v12101150.
4
Have deaths from COVID-19 in Europe plateaued due to herd immunity?欧洲因群体免疫而导致的新冠死亡人数是否已趋于平稳?
Lancet. 2020 Jun 20;395(10241):e110-e111. doi: 10.1016/S0140-6736(20)31357-X. Epub 2020 Jun 11.
5
Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.群体免疫——评估受影响国家遏制新冠疫情所需的群体免疫水平。
J Infect. 2020 Jun;80(6):e32-e33. doi: 10.1016/j.jinf.2020.03.027. Epub 2020 Mar 21.
6
Relation between BCG coverage rate and COVID-19 infection worldwide.全球范围内卡介苗接种率与新冠病毒感染之间的关系。
Med Hypotheses. 2020 Sep;142:109816. doi: 10.1016/j.mehy.2020.109816. Epub 2020 May 6.
7
A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2.一个数学模型揭示了人群异质性对 SARS-CoV-2 群体免疫的影响。
Science. 2020 Aug 14;369(6505):846-849. doi: 10.1126/science.abc6810. Epub 2020 Jun 23.
8
Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?逐步且可控的群体保护方法是遏制新冠疫情的有效策略吗?
Indian Pediatr. 2020 Jun 15;57(6):505-507. doi: 10.1007/s13312-020-1844-4. Epub 2020 May 6.
9
Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.长期和群体免疫对 SARS-CoV-2 的影响:基于当前和既往知识的推断。
Pathog Dis. 2020 Apr 1;78(3). doi: 10.1093/femspd/ftaa025.
10
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.迈向 COVID-19 群体免疫的漫长道路:疫苗平台技术和大规模免疫策略。
Front Immunol. 2020 Jul 21;11:1817. doi: 10.3389/fimmu.2020.01817. eCollection 2020.

引用本文的文献

1
A cross-sectional study of the predictors of COVID-19 vaccine hesitancy in Pakistan.一项关于巴基斯坦新冠疫苗犹豫因素的横断面研究。
Hum Vaccin Immunother. 2025 Dec;21(1):2549164. doi: 10.1080/21645515.2025.2549164. Epub 2025 Aug 27.
2
MCMC-Driven mathematical modeling of the impact of HPV vaccine uptake in reducing cervical cancer.基于马尔可夫链蒙特卡罗方法驱动的HPV疫苗接种对降低宫颈癌影响的数学建模
Sci Afr. 2025 Jun;28:None. doi: 10.1016/j.sciaf.2025.e02633.
3
Prevalence and Predictors of Intention to be Vaccinated Against COVID-19 in Thirteen Latin American and Caribbean Countries.

本文引用的文献

1
COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis.COVID-19的临床特征及性别特异性死亡风险:系统评价与荟萃分析
Front Med (Lausanne). 2020 Jul 21;7:459. doi: 10.3389/fmed.2020.00459. eCollection 2020.
2
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.预测 SARS-CoV-2 的传播动力学,直至大流行后期。
Science. 2020 May 22;368(6493):860-868. doi: 10.1126/science.abb5793. Epub 2020 Apr 14.
3
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.
13个拉丁美洲和加勒比国家中新冠疫苗接种意愿的流行情况及预测因素
Trends Psychol. 2022 Mar 21:1-25. doi: 10.1007/s43076-022-00170-x.
4
Collective Immunity to the Measles, Mumps, and Rubella Viruses in the Kyrgyz Population.吉尔吉斯斯坦人群对麻疹、腮腺炎和风疹病毒的群体免疫
Vaccines (Basel). 2025 Feb 27;13(3):249. doi: 10.3390/vaccines13030249.
5
Vaccination burnout impedes the compliance with multiple-dose administration of vaccines.疫苗接种倦怠阻碍了多剂次疫苗接种的依从性。
Sci Rep. 2025 Apr 17;15(1):13269. doi: 10.1038/s41598-025-97959-4.
6
The effectiveness of COVID-19 Heterologous Vaccination: the experience from a Regional Hospital in Cameroon.新冠病毒异源疫苗接种的有效性:喀麦隆一家地区医院的经验
Afr Health Sci. 2024 Dec;24(4):85-90. doi: 10.4314/ahs.v24i4.11.
7
Epidemiological and phylogenetic analyses of public SARS-CoV-2 data from Malawi.马拉维新冠病毒公共数据的流行病学和系统发育分析。
PLOS Glob Public Health. 2025 Mar 21;5(3):e0003943. doi: 10.1371/journal.pgph.0003943. eCollection 2025.
8
Real-world COVID-19 vaccine effectiveness in Zimbabwe: A test-negative case-control study.津巴布韦新冠疫苗在现实世界中的有效性:一项检测呈阴性的病例对照研究。
J Public Health Afr. 2025 Feb 19;16(1):695. doi: 10.4102/jphia.v16i1.695. eCollection 2025.
9
How Does Vaccine-Induced Immunity Compare to Infection-Acquired Immunity in the Dynamics of COVID-19?在新冠病毒病的动态变化中,疫苗诱导的免疫与感染获得的免疫相比如何?
Pathogens. 2025 Feb 11;14(2):179. doi: 10.3390/pathogens14020179.
10
Optimal vaccination policy to prevent endemicity: a stochastic model.预防地方性流行的最佳疫苗接种策略:一个随机模型。
J Math Biol. 2024 Dec 19;90(1):10. doi: 10.1007/s00285-024-02171-z.
从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.
4
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2.高传染性和严重急性呼吸综合征冠状病毒 2 的快速传播。
Emerg Infect Dis. 2020 Jul;26(7):1470-1477. doi: 10.3201/eid2607.200282. Epub 2020 Jun 21.
5
Estimates of the severity of coronavirus disease 2019: a model-based analysis.新型冠状病毒疾病 2019 严重程度的估计:基于模型的分析。
Lancet Infect Dis. 2020 Jun;20(6):669-677. doi: 10.1016/S1473-3099(20)30243-7. Epub 2020 Mar 30.
6
Secondary attack rate and superspreading events for SARS-CoV-2.新型冠状病毒2(SARS-CoV-2)的二代发病率和超级传播事件
Lancet. 2020 Mar 14;395(10227):e47. doi: 10.1016/S0140-6736(20)30462-1. Epub 2020 Feb 27.
7
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Complexity of the Basic Reproduction Number (R).基本繁殖数(R)的复杂性。
Emerg Infect Dis. 2019 Jan;25(1):1-4. doi: 10.3201/eid2501.171901.
10
Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance.SARS患者抗SARS冠状病毒抗体的动态变化及其临床意义
Respirology. 2006 Jan;11(1):49-53. doi: 10.1111/j.1440-1843.2006.00783.x.